https://www.selleckchem.com/pr....oducts/senaparib.htm
001). There was a significant correlation between NT-proBNP and worsening DD (Spearman's rho r = 0.54 for 2016 and r = 0.24 for 2009 algorithms, both p less then 0.001). Worse DD was associated with worse clinical presentation and increased risk of events (HR for the cumulative incidence of heart failure and death during follow-up 2.15 [95% CI 1.66-2.78, p less then 0.001] and 1.82 [95% CI 1.39-2.40, p less then 0.001] for 2016 and 2009 classifications, respectively, all p less then 0.001). CONCLUSIONS The agreement between 2016 and 2